Medscape

The event emphasizes additional measures for obesity therapy.

What to expect at Academy of Managed Care Pharmacy (AMCP) Nexus 2023

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

As demand for GLP-1a drugs for weight loss has increased, new data provides additional insights about this new class of medications.

Manufacturer: Ferring / Seikagaku Proposed indications Radicular leg pain associated with lumbar disc herniation (LDH) Clinical overview Mechanism of action Condoliase, also known as chondroitin...

Manufacturer: Abeona Proposed indications Recessive dystrophic epidermolysis bullosa (RDEB) Clinical overview Mechanism of action Prademagene zamikeracel (pz-cel) is an autologous, collagen type...

Forbes

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

The American Journal of Managed Care (AJMC): The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still...